Please join us for the April 20th, 2012 INpact meeting from 11:30AM-1:00PM in Indianapolis, Indiana. Gretchen Bowker, Pearl Pathways COO, will serve as a panelist for the discussion. The topic of discussion will be about the FDA 510(k) process and how it will change and affect medical device companies. To learn more, click here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Pearl IRB 2023 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests
Common Rule Exceptions to the Use of a Single IRB for Multi-site Research Ends After May 11, 2023
Pearl IRB 2022 Year-End Schedule